Assignee
BOSTONGENE CORP
US·36 granted patents·26 pending applications·164 citations·filing 2018–2025
Top patents by PatentIndex Score
62 records- 0197US11302420B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Apr 12, 2022·8 cites·30 claims
- 0297US10580517B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Mar 3, 2020·11 cites·30 claims
- 0397US10311967B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 4, 2019·25 cites·25 claims
- 0496US10340030B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2018·Granted Jul 2, 2019·13 cites·22 claims
- 0596US10340031B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2018·Granted Jul 2, 2019·13 cites·24 claims
- 0695US11705220B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2021·Granted Jul 18, 2023·2 cites·16 claims
- 0795US11373733B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Jun 28, 2022·3 cites·20 claims
- 0895US10650911B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 12, 2020·8 cites·11 claims
- 0995US10504615B2Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Dec 10, 2019·9 cites·30 claims
- 1095US10395761B1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Aug 27, 2019·9 cites·30 claims
- 1193USD891446SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Jul 28, 2020·4 cites·1 claims
- 1292US11367509B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 21, 2022·4 cites·21 claims
- 1392US11004542B2Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impactBOSTONGENE CORP·Filed 2020·Granted May 11, 2021·2 cites·16 claims
- 1492USD890779SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Jul 21, 2020·3 cites·1 claims
- 1591US10720230B2Method for administering a checkpoint blockade therapy to a subjectBOSTONGENE CORP·Filed 2018·Granted Jul 21, 2020·4 cites·9 claims
- 1691US10706954B2Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapyBOSTONGENE CORP·Filed 2019·Granted Jul 7, 2020·3 cites·16 claims
- 1790US11430545B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Aug 30, 2022·2 cites·23 claims
- 1890US11322226B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 3, 2022·2 cites·16 claims
- 1990US10636513B2Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 2090US10636514B2Using subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and therapy scoresBOSTONGENE CORP·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 2190US2024290434A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 2289US11587642B2Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2022·Granted Feb 21, 2023·2 cites·20 claims
- 2389US2024006029A1Systems and methods for predicting therapy efficacy from normalized biomarker scoresBOSTONGENE CORP·Filed 2023·Application pending·0 cites
- 2487US11315658B2Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2021·Granted Apr 26, 2022·5 cites·15 claims
- 2587US11250568B2Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2021·Granted Feb 15, 2022·3 cites·31 claims
- 2683US2022389512A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2782US11984200B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 14, 2024·1 cites·20 claims
- 2877US11482301B2Gene expression analysis techniques using gene rankings and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2020·Granted Oct 25, 2022·1 cites·33 claims
- 2975US11842797B2Systems and methods for predicting therapy efficacy from normalized biomarker scoresBOSTONGENE CORP·Filed 2019·Granted Dec 12, 2023·0 cites·20 claims
- 3074US12205675B2Techniques for bias correction in sequence dataBOSTONGENE CORP·Filed 2020·Granted Jan 21, 2025·1 cites·1 claims
- 3174US11568959B2Tumor microenvironment-based methods for assessing CAR-T and other immunotherapiesBOSTONGENE CORP·Filed 2021·Granted Jan 31, 2023·1 cites·4 claims
- 3274US2023178178A1Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3373USD892825SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Aug 11, 2020·13 cites·1 claims
- 3471US2025125013A1Hierarchical machine learning techniques for identifying molecular categories from expression dataBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 3569US2024161284A1Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 3669US2026038698A1Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltrationBOSTONGENE CORP·Filed 2025·Application pending·0 cites
- 3768US2022375543A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3868US2024379188A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3967US2024029884A1Techniques for detecting homologous recombination deficiency (hrd)BOSTONGENE CORP·Filed 2023·Application pending·0 cites
- 4066US12462941B2Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltrationBOSTONGENE CORP·Filed 2024·Granted Nov 4, 2025·0 cites·19 claims
- 4166US2023073731A1Gene expression analysis techniques using gene ranking and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 4264US2025029677A1Techniques for identifying her2-low breast cancer tumorsBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 4363US11915422B2Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2021·Granted Feb 27, 2024·0 cites·31 claims
- 4463US2022119881A1Systems and methods for sample preparation, sample sequencing, and sequencing data bias correction and quality controlBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 4563US2022307088A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 4663US2022223227A1Machine learning techniques for identifying malignant b- and t-cell populationsBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 4760US12580049B2Tumor microenvironment-based methods for assessing CAR-T and other immunotherapiesBOSTONGENE CORP·Filed 2022·Granted Mar 17, 2026·0 cites·5 claims
- 4860US11904002B2Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccinesBOSTONGENE CORP·Filed 2019·Granted Feb 20, 2024·0 cites·6 claims
- 4960US2022290254A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 5060US2022186318A1Techniques for identifying follicular lymphoma typesBOSTONGENE CORP·Filed 2021·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →